FI117438B - Förfarande för framställning av optiskt anrikat bupivakain - Google Patents
Förfarande för framställning av optiskt anrikat bupivakain Download PDFInfo
- Publication number
- FI117438B FI117438B FI971711A FI971711A FI117438B FI 117438 B FI117438 B FI 117438B FI 971711 A FI971711 A FI 971711A FI 971711 A FI971711 A FI 971711A FI 117438 B FI117438 B FI 117438B
- Authority
- FI
- Finland
- Prior art keywords
- bupivacaine
- water
- optically enriched
- tartaric acid
- levobupivacaine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (8)
1. Förfarande för framställning av optiskt anrikat t bupivakain, vid vilket förfarande bupivakainet bringas att 5 reagera med ett vinsyra-resolveringsmedel i ett med vatten j blandbart organiskt lösningsmedium, kanne tecknat av att mediet innehäller 1 - 20 % vatten.
2. Förfarande enligt patentkrav 1, känneteck-nat av att mängden resolveringsmedel är under 0,5 ekviva- 10 lenter per en molekvivalent bupivakain.
3. Förfarande enligt patentkrav 2, kanne tee k-nat av att mängden resolveringsmedel är 0,2 - 0,5 molek-vivalenter per en molekvivalent bupivakain.
4. Förfarande enligt nägot av de föregäende pa-15 tentkraven, kännetecknat av att resolveringsmedlet är (S, S)-vinsyra.
5. Förfarande enligt nägot av de föregäende pa-tentkraven, kännetecknat av att lösningsmedlet omfat- tar en C; ,,-alkanol. . , ' : 20
6. Förfarande enligt nägot av de föregäende pa- tentkraven, kännetecknat av att mediet innehäller 1 - 5. vatten. d tttm·
7. Förfarande enligt nägot av de föregäende pa- • · . tentkraven, kännetecknat av att det ytterligare om- ;i ,, * 25 fattar konversion av det optiskt anrikade bupivakainet ; " tili ett hydrokloridsalt.
* * 8. Förfarande enligt nägot av de föregäende pa- ·* :’·* tentkraven, kännetecknat av att man framställer levo- • · · ί.ί ί bupivakain. • · · • · · ΐ • · ♦ • · • · • · · • · · » · • · ' • ♦ · • · ... • » ...··* • · · • ·· • · ’ V • ♦ *·* ··*·· • * .
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9421476A GB9421476D0 (en) | 1994-10-25 | 1994-10-25 | Process and salt |
GB9421476 | 1994-10-25 | ||
GBGB9504926.8A GB9504926D0 (en) | 1995-03-10 | 1995-03-10 | Crystallisation |
GB9504926 | 1995-03-10 | ||
PCT/GB1995/002513 WO1996012699A1 (en) | 1994-10-25 | 1995-10-23 | Crystallisation of levobupivacaine and analogues thereof |
GB9502513 | 1995-10-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI971711A FI971711A (sv) | 1997-04-22 |
FI971711A0 FI971711A0 (sv) | 1997-04-22 |
FI117438B true FI117438B (sv) | 2006-10-13 |
Family
ID=26305863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI971711A FI117438B (sv) | 1994-10-25 | 1997-04-22 | Förfarande för framställning av optiskt anrikat bupivakain |
Country Status (16)
Country | Link |
---|---|
US (1) | US5994548A (sv) |
EP (1) | EP0788480B1 (sv) |
JP (1) | JP3911545B2 (sv) |
AT (1) | ATE245629T1 (sv) |
AU (1) | AU698637B2 (sv) |
CA (1) | CA2200355C (sv) |
DE (1) | DE69531356T2 (sv) |
DK (1) | DK0788480T3 (sv) |
ES (1) | ES2202375T3 (sv) |
FI (1) | FI117438B (sv) |
HU (1) | HU227420B1 (sv) |
MX (1) | MX9703024A (sv) |
NO (1) | NO309266B1 (sv) |
PL (1) | PL183210B1 (sv) |
PT (1) | PT788480E (sv) |
WO (1) | WO1996012699A1 (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0002246A (pt) | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
BRPI0104491B8 (pt) * | 2001-10-10 | 2021-05-25 | Cristalia Produtos Quim Farmaceuticos Ltda | n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica. |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
DK1575569T3 (da) | 2002-12-13 | 2011-01-10 | Durect Corp | Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet |
US6790267B1 (en) * | 2003-04-24 | 2004-09-14 | Xerox Corporation | Colorant compositions |
US7094812B2 (en) * | 2003-04-24 | 2006-08-22 | Xerox Corporations | Colorant compositions |
EA014852B1 (ru) | 2004-09-17 | 2011-02-28 | Дьюрект Корпорейшн | Система контролируемой доставки |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US20090187024A1 (en) * | 2006-04-25 | 2009-07-23 | Dishman Pharmaceuticals And Chemicals Ltd. | Ropivacaine hydrochloride anhydrate and the preparation thereof |
PT2117521E (pt) | 2006-11-03 | 2012-09-10 | Durect Corp | Sistemas de administração transdérmica que compreendem bupivacaína |
AU2008347158B8 (en) | 2007-12-06 | 2013-08-22 | Durect Corporation | Oral pharmaceutical dosage forms |
ATE555093T1 (de) * | 2008-01-15 | 2012-05-15 | Pharmathen Sa | Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
CN103073484B (zh) * | 2013-01-28 | 2014-10-22 | 山东诚创医药技术开发有限公司 | 一种甲哌卡因及其光学对映体的制备方法 |
CN105120659A (zh) | 2013-03-15 | 2015-12-02 | 度瑞公司 | 用于降低溶解可变性的具有流变改性剂的组合物 |
US11000487B2 (en) * | 2016-12-26 | 2021-05-11 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
CN115666621A (zh) | 2020-01-13 | 2023-01-31 | 度勒科特公司 | 具有减少的杂质的持续释放药物递送系统及相关方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE341404B (sv) * | 1967-05-18 | 1971-12-27 | Sterling Drug Inc | |
US4695576A (en) * | 1984-07-09 | 1987-09-22 | Astra Lake Medel Aktiebolag | L-N-n-propylpipecolic acid-2,6-xylidide |
-
1995
- 1995-10-23 EP EP95934738A patent/EP0788480B1/en not_active Expired - Lifetime
- 1995-10-23 DK DK95934738T patent/DK0788480T3/da active
- 1995-10-23 DE DE69531356T patent/DE69531356T2/de not_active Expired - Lifetime
- 1995-10-23 JP JP51373896A patent/JP3911545B2/ja not_active Expired - Lifetime
- 1995-10-23 WO PCT/GB1995/002513 patent/WO1996012699A1/en active IP Right Grant
- 1995-10-23 PL PL95319829A patent/PL183210B1/pl unknown
- 1995-10-23 US US08/849,418 patent/US5994548A/en not_active Expired - Lifetime
- 1995-10-23 CA CA002200355A patent/CA2200355C/en not_active Expired - Lifetime
- 1995-10-23 MX MX9703024A patent/MX9703024A/es unknown
- 1995-10-23 AT AT95934738T patent/ATE245629T1/de active
- 1995-10-23 PT PT95934738T patent/PT788480E/pt unknown
- 1995-10-23 ES ES95934738T patent/ES2202375T3/es not_active Expired - Lifetime
- 1995-10-23 HU HU9702372A patent/HU227420B1/hu unknown
- 1995-10-23 AU AU37048/95A patent/AU698637B2/en not_active Expired
-
1997
- 1997-04-22 FI FI971711A patent/FI117438B/sv not_active IP Right Cessation
- 1997-04-24 NO NO971903A patent/NO309266B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUT77631A (hu) | 1998-06-29 |
NO309266B1 (no) | 2001-01-08 |
ATE245629T1 (de) | 2003-08-15 |
AU3704895A (en) | 1996-05-15 |
US5994548A (en) | 1999-11-30 |
CA2200355A1 (en) | 1996-05-02 |
HU227420B1 (en) | 2011-05-30 |
EP0788480B1 (en) | 2003-07-23 |
CA2200355C (en) | 2007-03-06 |
ES2202375T3 (es) | 2004-04-01 |
AU698637B2 (en) | 1998-11-05 |
PL319829A1 (en) | 1997-09-01 |
MX9703024A (es) | 1997-10-31 |
FI971711A (sv) | 1997-04-22 |
PT788480E (pt) | 2003-12-31 |
WO1996012699A1 (en) | 1996-05-02 |
DK0788480T3 (da) | 2003-09-29 |
FI971711A0 (sv) | 1997-04-22 |
NO971903D0 (no) | 1997-04-24 |
EP0788480A1 (en) | 1997-08-13 |
JPH10507464A (ja) | 1998-07-21 |
DE69531356D1 (de) | 2003-08-28 |
JP3911545B2 (ja) | 2007-05-09 |
DE69531356T2 (de) | 2004-05-27 |
NO971903L (no) | 1997-04-24 |
PL183210B1 (pl) | 2002-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI117438B (sv) | Förfarande för framställning av optiskt anrikat bupivakain | |
RU2009128C1 (ru) | Гидрохлориды производных 1-бензил-4[(1-инданон)]-метилпиперидина | |
US20060276654A1 (en) | Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom | |
JP4015696B2 (ja) | レボブピバカインと同類のピペリジンカルボキサニリド麻酔剤の製造に用いるラセミ化法 | |
AU696875B2 (en) | New process for the preparation of ropivacaine hydrochloride monohydrate | |
US20110065755A1 (en) | Stable r(+)-lansoprazole amine salt and a process for preparing the same | |
WO2016038422A1 (en) | Process for the preparation of optically enriched adrenaline | |
DE3625738A1 (de) | 2-acyloxypropylamin-derivate, verfahren zu deren herstellung und deren verwendung | |
US6521792B2 (en) | Process for separating the diastereomeric bases of 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cylohexanol | |
DK152752B (da) | Fremgangsmaade til fremstilling af l-sulpirid | |
EP3074397B1 (en) | A process for preparation of (2s, 5r)-7-oxo-n-[(2s)-pyrrolidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide | |
DK1988086T4 (en) | Method of dissolving citalopram via its (S) -riched citalopram tartrate compound | |
US20080167470A1 (en) | Process of enantiomeric resolution of D,L-(+_)-threo-methylphenidate | |
KR100472609B1 (ko) | 레보부피바카인과그의유사체의결정화벙법 | |
US5929242A (en) | Manufacture of levobupivacaine and analogues thereof from L-lysine | |
JPH1036327A (ja) | 1−(3−メトキシフェニル)エチルアミンの光学活性体の製造方法 | |
JPS6383056A (ja) | ジアステレオマーの分割 | |
US20080171885A1 (en) | Process for Preparation of Highly Pure Trandolapril | |
JPH08245530A (ja) | 光学活性t−ロイシノールの製造方法、4−t−ブチル−2−オキサゾリジノン、オキサゾリン、二環式ラクタム、メルカプトフェニルオキサゾリン、ビスオキサコリンまたはビス(オキサゾリニル)ピリジンの製造方法、医薬または植物保護における有効物質の非対称的合成法および製造方法、および新規化合物 | |
EP0434743A4 (en) | Methods for preparing captopril and its analogues | |
JPS61268633A (ja) | ラセミ有機アミンの光学分割方法 | |
EP0432204A4 (en) | Derivatives and precursors of captopril and its analogues | |
JPH05255243A (ja) | アジリジン−2−カルボン酸誘導体及びその製造方法 | |
MXPA97008494A (en) | New process for the preparation of clorhidratode ropivacain monohidrat | |
HU207831B (en) | Process for producing enanthiomere mixtures of nitrogen-containing bases dividing raceme composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 117438 Country of ref document: FI |
|
MA | Patent expired |